Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET

Circulation Journal

Volumn 75, Issue 11, 2011, Pages 2628-2634

  Yoshinaga, Keiichiro ^a   Katoh, Chietsugu ^a   Manabe, Osamu ^a   Klein, Ran ^a,b   Naya, Masanao ^a   Sakakibara, Mamoru ^a   Yamada, Shiro ^a   de Kemp, Robert A ^b   Tsutsui, Hiroyuki ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Blood flow; Coronary artery disease; Myocardial perfusion imaging; Positron emission tomography; Rubidium 82

Indexed keywords

ADENOSINE TRIPHOSPHATE; RUBIDIUM 82;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DIAGNOSTIC VALUE; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; HYPEREMIA; MALE; POSITRON EMISSION TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; REGIONAL BLOOD FLOW; RUBIDIUM RADIOISOTOPES;

EID: 80054895116     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0502     Document Type: Article

References (39)

1. Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation 2007; 116: 2762-2772.
2. Katritsis DG, Meier B. Percutaneous coronary intervention for stable coronary artery disease. J Am Coll Cardiol 2008; 52: 889-893.
3. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
4. Klocke FJ, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidlines for the clinical use of radionuclide imaging). American College of Cardiology Web Site 2003. http://www.cardiosource.org (accessed July 31, 2006).
5. Usui Y, Chikamori T, Nakajima K, Hida S, Yamashina A, Nishimura T. Prognostic value of post-ischemic stunning as assessed by gated myocardial perfusion single-photon emission computed tomography: A subanalysis of the J-access study. Circ J 2010; 74: 1591-1599.
6. Yoshinaga K, Manabe O, Tamaki N. Physiological assessment of myocardial perfusion using nuclear cardiology would enhance coronary artery disease patient care: Which imaging modality is best for evaluation of myocardial ischemia? (SPECT-side) Circ J 2011; 75: 713-722; discussion 731.
7. Matsuo S, Nakajima K, Yamasaki Y, Kashiwagi A, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes: A study based on the J-access-2 database. Circ J 2010; 74: 1916-1921.
8. Matsumoto N, Nagao K, Hirayama A, Sato Y. Non-invasive assessment and clinical strategy of stable coronary artery disease by magnetic resonance imaging, multislice computed tomography and myocardial perfusion SPECT. Circ J 2010; 74: 34-40.
9. Beanlands RS, Chow BJ, Dick A, Friedrich MG, Gulenchyn KY, Kiess M, et al. CCS/CAR/CANM/CNCS/CANSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. Can J Cardiol 2007; 23: 107-119.
10. Bengel FM, Higuchi T, Javadi MS, Lautamaki R. Cardiac positron emission tomography. J Am Coll Cardiol 2009; 54: 1-15.
11. Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006; 13: 24-33.
12. Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007; 49: 1052-1058.
13. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-840.
14. Yoshinaga K, Chow BJ, deKemp RA, Thorn S, Ruddy TD, Davies RA, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des 2005; 11: 903-932.
15. Hajjiri MM, Leavitt MB, Zheng H, Spooner AE, Fischman AJ, Gewirtz H. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imaging 2009; 2: 751-758.
16. Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, Ito Y, et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET. J Nucl Cardiol 2003; 10: 275-283.
17. Yoshinaga K, Klein R, Tamaki N. Generator-produced rubidium-82 positron emission tomography myocardial perfusion imaging-from basic aspects to clinical applications. J Cardiol 2010; 55: 163-173.
18. Manabe O, Yoshinaga K, Katoh C, Naya M, DeKemp RA, Tamaki N. Repeatability of rest and hyperemic myocardial blood flow measurements with Rb-82 dynamic PET. J Nucl Med 2009; 50: 68-71.
19. 13N-ammonia PET. J Nucl Med 2009; 50: 1062-1071.
20. Herrero P, Markham J, Shelton ME, Bergmann SR. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res 1992; 70: 496-507.
21. 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 2007; 34: 1765-1774.
22. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by pet simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996; 37: 1701-1712.
23. Klein R, Beanlands RS, deKemp RA. Quantification of myocardial blood flow and flow reserve: Technical aspects. J Nucl Cardiol 2010; 17: 555-570.
24. Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauschene L, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004; 11: 440-449.
25. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, et al. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients. J Am Coll Cardiol 2007; 50: 1144-1149.
26. 15O and PET. J Nucl Med 2006; 47: 1420-1426.
27. 15O-labelled water PET. Eur J Nucl Med Mol Imaging 2010; 37: 2233-2241.
28. Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006; 48: 1029-1039.
29. 15O-water positron emission tomography. Circulation 2002; 105: 2878-2884.
30. American Society of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures: Part 2. J Nucl Cardiol 1999; 6: G47-G84.
31. 15O-water with PET. J Nucl Med 2004; 45: 1908-1916.
32. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
33. Lautamaki R, George RT, Kitagawa K, Higuchi T, Merrill J, Voicu C, et al. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: Validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging 2009; 36: 576-586.
34. 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 2008; 35: 1593-1601.
35. 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009; 54: 150-156.
36. Yoshinaga K, Tamaki N, Ruddy T, DeKemp RA, Beanlands R. Evaluation of myocardial perfusion. In: Wahl R, editor. Principles and practice of PET and PET/CT. 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2009; 541-564.
37. Di Carli MF. Advances in positron emission tomography. J Nucl Cardiol 2004; 11: 719-732.
38. deKemp RA, Yoshinaga K, Beanlands RS. Will 3-dimensional PETCT enable the routine quantification of myocardial blood flow? J Nucl Cardiol 2007; 14: 380-397.
39. Uren NG, Marraccini P, Gistri R, de Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 1993; 22: 650-658.